BHS Myeloma Committee event: Optimising the use of bispecific antibodies in multiple myeloma
Hof ter Musschen
Av. Emmanuel Mounierlaan 2
1200 Brussels
The BHS Myeloma Committee is pleased to invite hematologists, hematologists-in-training, and nurse specialists to their symposium on "Optimising the use of bispecific antibodies in multiple myeloma" to be held on Friday, 15 March in Hof ter Musschen (Brussels)*.
* Only the sponsors of this event can attend.
Program
13:45-14:00: Onsite registration
14:00-14:05: Welcome and Introduction (Chair: Michel Delforge, UZ Leuven)
Part 1: BCMA targeting agents (Chair: Nathalie Meuleman, HUB Institut Jules Bordet)
14:05 - 14:30: Clinical results with BCMA targeting bispecifics (Julien Depaus, CHU UCL Namur, site Godinne)
14:30 – 15:00: Managing side effects of BCMA targeting bispecifics (Michel Delforge, UZ Leuven)
15:00 – 15:20: Panel discussion
15:20 – 15:45: Coffee break
Part 2: Other targets (Chair: Marie-Christiane Vekemans, UCLouvain Saint-Luc)
15:45 - 16:15: Clinical results with non-BCMA targeting bispecifics (Jo Caers, CHU Liège)
16:15 – 16:45: Managing side effects of non-BCMA targeting bispecfics (Nicolas Kint, UZ Gent)
16:45 – 17:15: Panel discussion including therapeutic strategies post-bispecific treatment
17:30: Closure
Sponsors
